Network Meetings
A central record of the scientific gatherings, workshops, and progress sessions across both subnetworks, bringing together our clinical cohorts and immunological hubs.
Major Network Meetings
Inaugural Launch Meeting 2024
13-14 September 2024 • London, United KingdomWe started our work together in London at Imperial College. Over two days in South Kensington, our iSpy-Lifers and iSpy-Explorers met face-to-face to share what each clinical site and laboratory is working on, agree on how we collect and share samples across cohorts, and set up our joint Clinical, Microbiology, and Immunology working groups for the five-year programme.
Bringing the Global Hubs Together
Investigators from across our 16 partner institutions connected in London to align longitudinal cohort sampling in children and adults with systems serology, T cell assays, and experimental challenge studies.
- Shared protocols across paediatric and adult clinical cohorts
- Direct sample and reagent exchange between laboratories
- Joint Clinical, Microbiology, and Immunology working groups
Brisbane Networking Meeting
May 2025 • Brisbane, AustraliaFollowing the Lancefield meeting in Australia, our iSpy-Lifers and iSpy-Explorers gathered together in Brisbane to catch up on emerging data from the hubs and search for more ways to work collaboratively across the network.
Public Outreach & Featured Podcast
“GAS, Streptococcus pyogenes: Call It What You Want, It’s Got a Big Reputation”
Hear our iSpy-Lifers and iSpy-Explorers discuss the global burden of , clinical disease manifestations, human challenge trials, and how the network is working together to accelerate a safe, globally effective vaccine.
Sub-network Progress Sessions
Recordings are only available for our iSpy-Lifers and iSpy-Explorers.
Meeting recordings are exclusively for our iSpy-Lifers and iSpy-Explorers. If you missed a bimonthly or monthly update, click below or select any session date to request access.
Bimonthly Updates
Regular progress sessions focusing on longitudinal cohort data, experimental models, and unbiased antigen discovery.
Monthly Updates
Monthly reviews of controlled human infection model (CHIM) data, high-resolution systems serology, and preclinical vaccine efficacy to pinpoint precise immune correlates.